75987-130 : Tepezza 500 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 75987-130
Labeler: Horizon Therapeutics USA, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tepezza
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA761143
Rev. Date: 


NDC Package Codes:

  • 75987-130-15: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (75987‑130‑15) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Teprotumumab

Dosage Strength:

  • 500 mg

Pharmaceutical Classes:

  • Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]
  • Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 75987-130 QR Code

< Prev: 75987-111Next: 75987-140 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.